Last updated: May 29, 2026

Mcbee Moore & Vanik, Ip, LLC

87 pending office actions • 30 clients • 77 examiners • 45 art units • 0 of 87 (0%) have an AI response strategy ready • 85 patents granted in the last 365 days

Portfolio Summary

Total Pending OAs

Non-Final OAs

Final Rejections

Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 86 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

Overdue

Due this week

Due this month

Due in next 60 days

Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 86 of the docket's apps have a known mailing date.

Overdue (51)Due ≤ 7 days (3)Due ≤ 30 days (18)Due ≤ 60 days (8)Due later (6)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

Hard (3%)

Medium (68%)

Easy (10%)

Unknown (18%)

Rejection Statute Mix

Bucket	Cases
§101 only	3 (3%)
§103 only	50 (57%)
§102 only	7 (8%)
§112 only	9 (10%)
Double-patenting + other	2 (2%)
No statute on record	16 (18%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

Life Sciences

95% of docket

Information Tech

0% of docket

Communications

1% of docket

Semiconductors

1% of docket

Mechanical / Eng

2% of docket

Business / Other

0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

870 h

Manual time on pending OAs

174 h

Time saved (low, 20%)

304 h

Time saved (mid, 35%)

7.6 wks

FTE-weeks freed (mid)

Top Examiners on this docket

Examiner	Apps on this docket	Allow rate	Interview lift
YOUTCHOM PENDIE, EMMANUEL LED	3	60.0%	+50.0%
SMITH, CATHERINE P	2	16.1%	+12.3%
PRAKASH, SUBBALAKSHMI	2	45.0%	+37.2%
NATARAJAN, MEERA	2	62.2%	+16.8%
MATTISON, LORI K	2	14.6%	+26.4%
HUANG, MICKEY NMN	2	61.5%	+50.4%
CANELLA, KAREN A	2	62.6%	+32.9%
HAWKINS, AMANDA SALATA	2	0.0%	+0.0%
MORILLO, JANELL COMBS	2	57.5%	+25.9%
SPIES, BRADLEY R	1	73.8%	+20.9%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #	Title	Examiner	Due in
17430589	PROCESS FOR MANUFACTURING AN ALUMINUM ALLOY PART	SMITH, CATHERINE P	38d overdue
18552770	HAIR TREATMENT COMPOSITION AND HAIR TREATMENT METHOD	MATTISON, LORI K	15d overdue
18678051	ALUMINUM COPPER LITHIUM ALLOY WITH IMPROVED MECHANICAL STRENGTH AND TOUGHNESS	SMITH, CATHERINE P	10d overdue
17255852	FATTY ACID-GRAFTED HYALURONIC ACID, DERMAL FILLER FORMULATIONS COMPRISING SAME, PROCESS FOR PREPARATION AND USE THEREOF	MATTISON, LORI K	2d overdue
18551454	DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1)	COUNTS, GARY W	5d
17258670	HEALTHCARE MANAGEMENT METHOD	HRANEK, KAREN AMANDA	9d
17906118	USE OF PHYTASE TO OBTAIN IMPROVED FOOD	HAWKINS, AMANDA SALATA	26d
17842842	PROCESS FOR PRODUCING OLIVE OIL	HAWKINS, AMANDA SALATA	34d

Interview Candidates (18)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #	Title	Examiner	Due in
18546604	COATED MEAT OR FISH SUBSTITUTE	PRAKASH, SUBBALAKSHMI	112d overdue
19285278	SYSTEM AND METHOD FOR EXTRACTING NOXIOUS CHEMICALS FROM NATURALLY-OCCURRING RAW MATERIALS AND CREATING USEFUL PRODUCTS	SPIES, BRADLEY R	78d overdue
17781682	IMPROVED METHOD FOR MANUFACTURING A STRUCTURE COMPONENT FOR A MOTOR VEHICLE BODY	MORILLO, JANELL COMBS	70d overdue
18154091	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS	CANELLA, KAREN A	50d overdue
18154098	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS	CANELLA, KAREN A	49d overdue
17415590	AL-ZN-CU-MG ALLOYS AND THEIR MANUFACTURING PROCESS	MORILLO, JANELL COMBS	49d overdue
17430589	PROCESS FOR MANUFACTURING AN ALUMINUM ALLOY PART	SMITH, CATHERINE P	38d overdue
18262043	METHOD AND APPARATUS FOR EVALUATING DEGREE OF GLYCATION OF PROTEIN	HUANG, MICKEY NMN	19d overdue

Client Portfolio (30 clients)

Client (Assignee)	Pending OAs
dsm-firmenich	18
Immatics	15
Constellium	9
Elanco	7
PROVIGATE INC.	4
C-TEC CONSTELLIUM TECHNOLOGY CENTER	3
GenScript	2
CELLTREND GMBH	2
Elkem	2
Xavier University of Louisiana	2
IMMATICS US, INC.	2
CRAIF INC.	2
MERZ PHARMA GMBH & CO. KGAA	2
Plant Synergies, LLC	1
PHARAGEN LLC	1
NATIONAL CHENG KUNG UNIVERSITY	1
3N SOLUTIONS SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA	1
DSTYLE HOLDINGS CO., LTD.	1
CustomArray, Inc.	1
BAYER AKTIENGESELLSCHAFT	1
KARADENIZ TEKNIK ÜNIVERSITESI	1
MIT	1
Fluidiconic	1
AstraZeneca	1
THE UNIVERSITY OF TOKYO	1
University of Texas	1
EPFL	1
Charité - Universitätsmedizin Berlin	1
Trinity College Dublin	1
Thermo Fisher Scientific	1

Top Art Units

Art Unit	Apps
1793	8
1643	6
1647	5
1791	4
1733	4
1735	3
1784	3
1625	3
1642	3
1675	3

Pending Office Actions

App #	Title	Client	Examiner	Art Unit	Statutes	Status	Due in	AI	Filed
19285278	SYSTEM AND METHOD FOR EXTRACTING NOXIOUS CHEMICALS FROM NATURALLY-OCCURRING RAW MATERIALS AND CREATING USEFUL PRODUCTS	Plant Synergies, LLC	SPIES, BRADLEY R	1777	§103	Non-Final OA	78d overdue	Pending	Jul 30, 2025
18678051	ALUMINUM COPPER LITHIUM ALLOY WITH IMPROVED MECHANICAL STRENGTH AND TOUGHNESS	Constellium Issoire	SMITH, CATHERINE P	1735	§103	Final Rejection	10d overdue	Pending	May 30, 2024
18698609	NOVEL BINDER	DSM IP ASSETS B.V.	KERSHAW, KELLY P	1791	§103	Non-Final OA	70d	Pending	Apr 04, 2024
18691184	HIGH-MOISTURE TEXTURIZED VEGETABLE PROTEIN	DSM IP ASSETS B.V.	LIU, DEBORAH YANG-HAO	1791	§103	Non-Final OA	8d overdue	Pending	Mar 12, 2024
18691213	PLANT BASED READY TO MIX COMPOSITION	DSM IP ASSETS B.V.	LEBLANC, KATHERINE DEGUIRE	1791	§103	Non-Final OA	46d	Pending	Mar 12, 2024
18291819	PROCESS FOR PRODUCTION OF A FERMENTED MILK PRODUCT USING GLUCOSE-FRUCTOSE OXIDOREDUCTASE	DSM IP ASSETS B.V.	PRAKASH, SUBBALAKSHMI	1793	§103	Non-Final OA	12d	Pending	Jan 24, 2024
18538605	FORMULATIONS FOR TREATING ACID REFLUX COMPRISING SODIUM ALGINATE	Pharagen LLC	COHEN, MICHAEL P	1612	§103	Non-Final OA	13d	Pending	Dec 13, 2023
18569689	STRIP MADE OF 6XXX ALLOY AND MANUFACTURING PROCESS	Constellium Neuf-Brisach	KRUPICKA, ADAM C	1784	§103	Final Rejection	53d overdue	Pending	Dec 13, 2023
18569414	CRYSTALLINE FORMS OF ISOXAZOLINE COMPOUND	Elanco US, Inc.	ENGLISH, CONNOR KENNEDY	1625	§103	Non-Final OA	16d overdue	Pending	Dec 12, 2023
18565339	ELECTROGRAFTED FILMS FOR DNA SYNTHESIS	Nanjing Genscript Biotech Co., Ltd.	WONG, EDNA	1795	§112	Non-Final OA	43d	Pending	Nov 29, 2023
18511308	ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME	Immatics Biotechnologies GmbH	NATARAJAN, MEERA	1643	§112	Non-Final OA	76d	Pending	Nov 16, 2023
18560853	FISH FLAVOUR AND FISH ANALOGUE PRODUCT	DSM IP ASSETS B.V.	LACHICA, ERICSON M	1792	§103	Final Rejection	34d	Pending	Nov 14, 2023
18498472	METHOD OF INHIBITING LIPOGENESIS WITH UBIQUITIN-SPECIFIC PEPTIDASE 24 INHIBITOR COMPOSITION	National Cheng Kung University	SAMSELL, RILLA MARIE	1624	Other	Non-Final OA	21d	Pending	Oct 31, 2023
18558040	5XXX ALUMINIUM SHEETS FOR CAN MAKING	Constellium Rolled Products Singen GmbH & Co. Kg	CHRISTY, KATHERINE A	1784	§103	Non-Final OA	4d overdue	Pending	Oct 30, 2023
18483899	FROZEN ENZYME PELLETS	DSM IP ASSETS B.V.	LI, CHANGQING	1791	§103	Non-Final OA	91d overdue	Pending	Oct 10, 2023
18483718	LANCE OF A CLEANING KIT FOR MEDIUM-VOLTAGE POWER DEVICES	3N Solutions Spólka Z Ograniczona Odpowiedzialnoscia	CHAUDHRI, OMAIR	1711	§112	Non-Final OA	30d overdue	Pending	Oct 10, 2023
18552770	HAIR TREATMENT COMPOSITION AND HAIR TREATMENT METHOD	Dstyle Holdings Co., Ltd.	MATTISON, LORI K	1619	§103	Non-Final OA	15d overdue	Pending	Sep 27, 2023
18551834	UNIVERSAL LINKER REAGENTS FOR DNA SYNTHESIS	Customarray, Inc.	LEWIS, PATRICK T	1691	§103	Non-Final OA	3d overdue	Pending	Sep 21, 2023
18551614	PROCESS FOR PREPARING (2Z)-2-(PHENYLIMINO)-1,3-THIAZOLIDINE-4-ONE-SULFOXIDE DERIVATIVES IN AN ENANTIOMERICALLY ENRICHED FORM	BAYER AKTIENGESELLSCHAFT	OH, TAYLOR V	1625	§103	Non-Final OA	13d	Pending	Sep 21, 2023
18551454	DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1)	Celltrend GmbH	COUNTS, GARY W	1678	§101	Non-Final OA	5d	Pending	Sep 20, 2023
18547214	DURABLE ALUMINIUM ALLOY SHEET FOR DECORATIVE APPLICATIONS	Constellium Rolled Products Singen GmbH & Co.Kg	SU, XIAOWEI	1733	§103	Non-Final OA	11d overdue	Pending	Aug 21, 2023
18451216	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS	Immatics Biotechnologies GmbH	NICKOL, GARY B	1643	DPOther	Non-Final OA	69d	Pending	Aug 17, 2023
18546604	COATED MEAT OR FISH SUBSTITUTE	DSM IP ASSETS B.V.	PRAKASH, SUBBALAKSHMI	1793	§103	Non-Final OA	112d overdue	Pending	Aug 16, 2023
18263786	A METHOD OF ADDITIVE MANUFACTURE OF A THREE-DIMENSIONAL ARTICLE MADE OF A CURED MATERIAL AND A GEL LIKE SUPPORT FOR USE IN ADDITIVE MANUFACTURING	Elkem Silicones France SAS	ROELOFSE, CHRISTIAAN	1762	§103	Non-Final OA	27d	Pending	Aug 01, 2023
18262043	METHOD AND APPARATUS FOR EVALUATING DEGREE OF GLYCATION OF PROTEIN	Provigate Inc.	HUANG, MICKEY NMN	1758	§103	Non-Final OA	19d overdue	Pending	Jul 19, 2023
18347724	PHENYL UNSATURATED KETONES AS HUMAN FACTOR XIIIA INHIBITORS FOR TREATMENT OF THROMBOEMBOLIC DISEASES	Xavier University Of Louisiana	DEKARSKE, MADELINE MCGUIRE	1622	§103	Non-Final OA	13d	Pending	Jul 06, 2023
18347131	YOGURT SNACK	DSM IP ASSETS B.V.	O'HERN, BRENT T	1793	§112	Final Rejection	44d overdue	Pending	Jul 05, 2023
18323577	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS	Immatics Biotechnologies GmbH	YOUTCHOM PENDIE, EMMANUEL LED	1647	Other	Non-Final OA	34d	Pending	May 25, 2023
18253061	N-(2,3-DIHYDRO-1,4-BENZOXAZIN-4-YL)-3-ISOPROPYL-7-(2,3,5-TRIFLUOROPHENYL)BENZO-THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS FOR THE TREATMENT OF HEARTWORM INFECTIONS	Elanco Tiergesundheit AG	LEE, CHIHYI NMN	1628	Other	Non-Final OA	60d overdue	Pending	May 16, 2023
18315183	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS	Immatics Biotechnologies GmbH	MOSELEY II, NELSON B	1642	Other	Non-Final OA	27d	Pending	May 10, 2023
18314878	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS	Immatics Biotechnologies GmbH	YOUTCHOM PENDIE, EMMANUEL LED	1647	§103	Non-Final OA	63d	Pending	May 10, 2023
18312144	METHODS FOR IMPROVING T CELL EFFICACY	Immatics US, Inc.	YOUTCHOM PENDIE, EMMANUEL LED	1647	§103	Non-Final OA	8d	Pending	May 04, 2023
18250283	THREE-DIMENSIONED BIRD REPELLER	Karadeniz Teknik Üniversitesi	OKEBATO, SAHLU	2625	§103	Final Rejection	92d overdue	Pending	Apr 24, 2023
18301545	ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME	Immatics Biotechnologies GmbH	NATARAJAN, MEERA	1643	DPOther	Final Rejection	70d	Pending	Apr 17, 2023
17641054	BODY FLUID EXTRACT CONTAINING MICRO RNA	Craif Inc.	HOPPE, EMMA RUTH	1683	§101	Non-Final OA	70d	Pending	Apr 14, 2023
18297069	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS	Immatics Biotechnologies GmbH	MELCHIOR, JAMES RYLAND	1644	Other	Non-Final OA	60d overdue	Pending	Apr 07, 2023
18297076	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS	Immatics Biotechnologies GmbH	MERTZ, PREMA MARIA	1674	Other	Non-Final OA	112d overdue	Pending	Apr 07, 2023
18297064	PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS	Immatics Biotechnologies GmbH	STOICA, ELLY GERALD	1647	§112	Non-Final OA	79d overdue	Pending	Apr 07, 2023
18192743	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS	Immatics Biotechnologies GmbH	JUEDES, AMY E	1644	Other	Non-Final OA	120d overdue	Pending	Mar 30, 2023
18187937	GUIDE-RNA EXPRESSION SYSTEM FOR A HOST CELL	Massachusetts Institute Of Technology	KONOPKA, CATHERINE ANNE	1635	§103	Final Rejection	72d overdue	Pending	Mar 22, 2023
18185649	PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS	Immatics Biotechnologies GmbH	WU, JULIE ZHEN QIN	1643	Other	Non-Final OA	149d overdue	Pending	Mar 17, 2023
18245114	ANTIBODIES TARGETING HUMAN CLAUDIN 18.2 AND USES THEREOF	Nanjing Genscript Biotech Co., Ltd.	STONEBRAKER, ALYSSA RAE	1642	§102	Non-Final OA	4d overdue	Pending	Mar 13, 2023
18178055	PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS	Immatics Biotechnologies GmbH	FONTAINHAS, AURORA M	1675	Other	Non-Final OA	153d overdue	Pending	Mar 03, 2023
18043868	CHEWABLE FORMULATIONS	Elanco Tiergesundheit AG	SONG, JIANFENG	1613	§103	Non-Final OA	14d	Pending	Mar 02, 2023
18158734	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS	Immatics Biotechnologies GmbH	HAM, JIEUN	1600	§103	Non-Final OA	—	Pending	Jan 24, 2023
18156098	THERMOMECHANICAL AGEING FOR 6XXX EXTRUSIONS	CONSTELLIUM SINGEN GMBH	CARDA, DANIELLE MARIE	1738	§103	Non-Final OA	26d overdue	Pending	Jan 18, 2023
18154098	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS	Immatics Biotechnologies GmbH	CANELLA, KAREN A	1643	Other	Non-Final OA	49d overdue	Pending	Jan 13, 2023
18154091	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS	Immatics Biotechnologies GmbH	CANELLA, KAREN A	1643	§112	Non-Final OA	50d overdue	Pending	Jan 13, 2023
18002928	NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES	Elanco Animal Health GmbH	HEITMEIER, KENDALL NICOLE	1621	§102	Non-Final OA	3d overdue	Pending	Dec 22, 2022
18061322	MICROENVIRONMENT-SIMULATED CELL CULTURE SYSTEM	Fluidiconic Biotechnology Co., Ltd.	BOWERS, NATHAN ANDREW	1799	§103	Final Rejection	66d overdue	Pending	Dec 02, 2022
18000322	USE OF PRODUCTS MADE FROM ALUMINIUM COPPER MAGNESIUM ALLOY THAT PERFORM WELL AT HIGH TEMPERATURE	Constellium Issoire	SHAMS, NAZMUN NAHAR	1738	§103	Non-Final OA	31d overdue	Pending	Nov 30, 2022
17998339	DEVICE FOR CAUSING TEARS TO BE SECRETED	Provigate Inc.	GLOVER, NELSON ALEXANDER	3791	§103	Non-Final OA	118d overdue	Pending	Nov 09, 2022
18053705	ADOPTIVE CELL THERAPY COMBINATION TREATMENT AND COMPOSITIONS THEREOF	Immatics US, Inc.	LU, CHENG	1642	Other	Non-Final OA	6d	Pending	Nov 08, 2022
17920499	PROTEIN A CHROMATOGRAPHY PURIFICATION OF AN ANTIBODY	Alexion Pharmaceuticals, Inc.	HUANG, MICKEY NMN	1758	§103	Final Rejection	14d	Pending	Oct 21, 2022
17996557	LONG-ACTING ANTI-IL31 ANTIBODIES FOR VETERINARY USE	Elanco US Inc.	ALLEN, MARIANNE P	1647	§112	Non-Final OA	31d overdue	Pending	Oct 19, 2022
17996549	IL4/IL13 RECEPTOR MOLECULES FOR VETERINARY USE	Elanco US Inc.	KONOPELSKI SNAVEL, SARA ELIZABETH	1658	Other	Non-Final OA	19d overdue	Pending	Oct 19, 2022
17995968	METHOD FOR PRODUCING AN ALUMINIUM ALLOY PART	C-Tec Constellium Technology Center	HILL, STEPHANI A	1735	Other	Final Rejection	15d	Pending	Oct 11, 2022
17995750	SUBSTITUTED CONDENSED AZINES AS ANTHELMINTIC COMPOUNDS	Elanco Animal Health GmbH	RODRIGUEZ-GARCIA, VALERIE	1621	§103	Final Rejection	34d	Pending	Oct 07, 2022
17906118	USE OF PHYTASE TO OBTAIN IMPROVED FOOD	DSM IP ASSETS B.V.	HAWKINS, AMANDA SALATA	1793	§103	Non-Final OA	26d	Pending	Sep 12, 2022
17842842	PROCESS FOR PRODUCING OLIVE OIL	DSM IP ASSETS B.V.	HAWKINS, AMANDA SALATA	1793	§103	Non-Final OA	34d	Pending	Jun 17, 2022
17781682	IMPROVED METHOD FOR MANUFACTURING A STRUCTURE COMPONENT FOR A MOTOR VEHICLE BODY	Constellium Neuf-Brisach	MORILLO, JANELL COMBS	1733	§103	Non-Final OA	70d overdue	Pending	Jun 01, 2022
17780258	METHOD AND SYSTEM FOR PREDICTION OF A PERFORMANCE OF A STRAIN IN A PLANT	DSM IP ASSETS B.V.	BECKER, BRANDON J	2857	§103	Final Rejection	9d	Pending	May 26, 2022
17776404	LIBRARY OF BARCODED EXTRACELLULAR VESICLES	The University of Tokyo	LAFAVE, ELIZABETH ROSE	1684	§102	Final Rejection	51d overdue	Pending	May 12, 2022
17771391	PROTEIN KINASE INHIBITORS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISEASES	Xavier University Of Louisiana	MCANANY, JOHN D	1625	§103	Non-Final OA	26d overdue	Pending	Apr 22, 2022
17764104	IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER	BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM	PATTERSON, SARAH COOPER	1675	§103	Final Rejection	43d overdue	Pending	Mar 25, 2022
17762325	TREATMENT AND PREVENTION OF AGING RELATED-DISEASE AND/OR AGING BY THE INHIBITION OF SPHINGOLIPIDS	ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE	RAHMANI, NILOOFAR	1691	§102	Non-Final OA	7d	Pending	Mar 21, 2022
17425150	ANTIGEN MEASURING METHOD AND MEASURING APPARATUS	Provigate Inc.	MONTGOMERY, ANN Y	1678	§112	Non-Final OA	113d overdue	Pending	Mar 07, 2022
17640262	ENZYME COMPOSITION	DSM IP ASSETS B.V.	SELWANES, JOHN PAUL	1651	§103	Non-Final OA	1d overdue	Pending	Mar 03, 2022
17633664	DIAGNOSIS OF CANCER USING DETECTION OF ANTIBODIES DIRECTED AGAINST PD1 AND PD-L1	Celltrend GmbH	MACFARLANE, STACEY NEE	1675	§102	Non-Final OA	80d overdue	Pending	Feb 08, 2022
17603789	PHAGE TEST KIT	DSM IP ASSETS B.V.	ZOU, NIANXIANG	1671	§103	Non-Final OA	30d overdue	Pending	Oct 14, 2021
17442709	GREENHOUSE GAS IMPROVED FERMENTATION	DSM IP ASSETS B.V.	ESPERON, NATHAN GREGORY	1799	§103	Non-Final OA	12d	Pending	Sep 24, 2021
17289611	METHOD OF EXTRACTING MIRNA AND METHOD OF ANALYZING MIRNA	Craif Inc.	KRISHNAN, GANAPATHY	1693	Other	Non-Final OA	56d	Pending	Sep 24, 2021
17432391	DRUG DELIVERY SILICONE COMPOSITION TO IMPROVE ACTIVE INGREDIENT ELUTION	Elkem Silicones Germany GmbH	BOATENG, AFUA BAMFOAA	1617	§103	Non-Final OA	29d	Pending	Aug 19, 2021
17431997	NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR	Merz Pharma GmbH & Co. Kgaa	GOUGH, TIFFANY MAUREEN	1651	Other	Non-Final OA	44d overdue	Pending	Aug 18, 2021
17430589	PROCESS FOR MANUFACTURING AN ALUMINUM ALLOY PART	C-Tec Constellium Technology Center	SMITH, CATHERINE P	1735	§103	Non-Final OA	38d overdue	Pending	Aug 12, 2021
17415590	AL-ZN-CU-MG ALLOYS AND THEIR MANUFACTURING PROCESS	Constellium Issoire	MORILLO, JANELL COMBS	1733	§103	Non-Final OA	49d overdue	Pending	Jun 17, 2021
17414839	PHAGE RESISTANT LACTIC ACID BACTERIA	DSM IP ASSETS B.V.	SWIFT, CANDICE LEE	1657	§112	Non-Final OA	91d overdue	Pending	Jun 16, 2021
17258670	HEALTHCARE MANAGEMENT METHOD	Provigate Inc.	HRANEK, KAREN AMANDA	3684	§101	Final Rejection	9d	Pending	Jun 16, 2021
17297944	METHOD FOR PREDICTING THE RESPONSE TO CANCER IMMUNOTHERAPY IN CANCER PATIENTS	Charité - Universitätsmedizin Berlin	GROSS, CHRISTOPHER M	1684	§102	Non-Final OA	29d	Pending	May 27, 2021
17282326	PROCESS FOR MANUFACTURING AN ALUMINUM ALLOY PART	C-Tec Constellium Technology Center	LUK, VANESSA TIBAY	1733	§103	Non-Final OA	42d overdue	Pending	Apr 01, 2021
17255852	FATTY ACID-GRAFTED HYALURONIC ACID, DERMAL FILLER FORMULATIONS COMPRISING SAME, PROCESS FOR PREPARATION AND USE THEREOF	Merz Pharma GmbH & Co. Kgaa	MATTISON, LORI K	1619	§103	Final Rejection	2d overdue	Pending	Dec 23, 2020
15734727	MODIFIED RAPESEED PROTEIN ISOLATE	DSM IP ASSETS B.V.	TRAN, LIEN THUY	1793	§103	Non-Final OA	45d overdue	Pending	Dec 03, 2020
15734102	USE OF PEPTIDYLARGININE DEIMINASE TO OBTAIN IMPROVED FOOD	DSM IP ASSETS B.V.	TURNER, FELICIA C	1793	§103	Non-Final OA	36d	Pending	Dec 01, 2020
17051672	METHOD FOR MANUFACTURING AN ALUMINUM-COPPER-LITHIUM ALLOY HAVING IMPROVED COMPRESSIVE STRENGTH AND IMPROVED TOUGHNESS	Constellium Issoire	OMORI, MARY I	1784	Other	Final Rejection	43d overdue	Pending	Oct 29, 2020
17009299	CHEESE HAVING SHEEP-LIKE AND/OR GOATY FLAVOUR ATTRIBUTES	DSM IP ASSETS B.V.	MCCLAIN, TYNESHA L.	1793	§103	Non-Final OA	70d overdue	Pending	Sep 01, 2020
16994283	USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION	The Provost, Fillows, Foundatio Scholars, & The Other Members Of Board, Of The College Of The Holy	HASAN, KHALEDA B	1636	§102	Non-Final OA	30d overdue	Pending	Aug 14, 2020
16646495	PROADRENOMEDULLIN AS INDICATOR FOR RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS	B.R.A.H.M.S GmbH	SAOUD, CHRISTINE J	1645	§103	Final Rejection	20d	Pending	Mar 11, 2020

Show all 87 rows (37 more)

Managing Mcbee Moore & Vanik, Ip, LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial